Home › NDC Lookup › RxCUI directory › RxCUI 1790546

Infliximab-dyyb 100 MG Injection [Inflectra] — RxCUI 1790546

RxNorm drug concept · Semantic branded drug
RxCUI 1790546 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1790546
Official nameInfliximab-dyyb 100 MG Injection [Inflectra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asInflectra 100 MG Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)21,959 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Infliximab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Infliximab is a biologic medication — a lab-made protein — that calms down the part of your immune system driving inflammation. It's given through an IV (into a vein) at an infusio...
  • What exactly is infliximab and how is it given to me?
  • The most common ones are infections — especially upper respiratory infections like colds or sinusitis — and infusion reactions, which can include flushing, headache, chills, or a r...
  • What are the most common side effects I should expect?
📖 Read our full Infliximab Injection guide →

🕸️ Concept Web — How Infliximab-dyyb 100 MG Injection [Inflectra] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Infliximab-dyyb 100 MG Injection [Inflectra] RxCUI 1790546

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Infliximab 191831
    • Infliximab-dyyb 1790539
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inflectra 1790542
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Infliximab Injection 1655941
    • Infliximab-dyyb Injection 2646209
    • Infliximab Injectable Product 1160692
    • Infliximab-dyyb Injectable Product 2662659
    • Infliximab Injection [Inflectra] 1790544
    • Infliximab-dyyb Injection [Inflectra] 2654474
    • Inflectra Injectable Product 1790545
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Infliximab-dyyb 100 MG Injection SCD · 1790541
  • Infliximab-dyyb 100 MG SCDC · 1790540
  • Infliximab Injection SCDF · 1655941
  • Infliximab-dyyb Injection SCDFP · 2646209
  • Infliximab Injectable Product SCDG · 1160692
  • Infliximab-dyyb Injectable Product SCDGP · 2662659

Brand-Name Concepts

  • Infliximab-dyyb 100 MG [Inflectra] SBDC · 1790543
  • Infliximab Injection [Inflectra] SBDF · 1790544
  • Infliximab-dyyb Injection [Inflectra] SBDFP · 2654474
  • Inflectra Injectable Product SBDG · 1790545
  • Inflectra BN · 1790542

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1790546 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0809-01 1 VIAL, SINGLE-USE in 1 CARTON (0069-0809-01) / 10 mL in 1... INFLECTRA Pfizer Laboratories Div Pfizer Inc 2016-11-21
Observed labelers: Pfizer Laboratories Div Pfizer Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5103 Injection, inflectra 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.